We help companies at early and late stage de-risk by preparing for in-house commercialization, partnership and exit strategy. This includes navigating through go-to-market strategy, early trial planning across regulatory, payers and medical stakeholders, evidence generation, value proposition and resource planning.

Wickenstones is a global strategy consultancy with expertise in evidence, value and access. We deliver excellence to our clients through a collaborative working model underpinned by our values of clarity, flexibility and value. We specialize in the pharmaceutical, biotech, diagnostic, and device sectors with offices in the US, UK and Europe.